Table 1.
Description of the study population
| Group | ID | Diagnosis | Phadiatop (kUA/L)* |
Der p- specific IgE (kUA/L) |
Total IgE (kUA/L) |
Eosinophil (cells/mm3) |
|---|---|---|---|---|---|---|
| Fil+A+ | 1 | Loa loa | 22.5 | 11.8 | 497.0 | 400 |
| Fil+A+ | 2 | W. bancrofti | 5.4 | 13.3 | 120.0 | 427 |
| Fil+A+ | 3 | O. volvulus | 48.0 | 16.1 | 755.0 | 3,080 |
| Fil+A+ | 4 | Loa loa | 43.4 | 38.5 | 1,244.0 | 7,520 |
| Fil+A+ | 5 | Loa loa | 5.3 | 4.8 | 9,296.0 | 1,408 |
| Fil+A+ | 6 | Loa loa | 26.4 | 2.3 | 11,794.0 | 10,414 |
| Fil+A+ | 7 | Loa loa | 30.8 | 45.7 | 1,269.0 | 7,283 |
| Fil+A+ | 8 | Loa loa | 4.1 | 3.2 | 6,206.0 | 1,404 |
| Fil+A+ | 9 | Loa loa | 1.4 | 0.6 | 606.0 | 4,218 |
| Fil+A+ | 10 | Loa loa | 35.7 | 2.1 | 1,774.0 | 3,267 |
| Fil+A+ | 11 | Loa loa | 1.4 | 0.7 | 1,506.0 | 1,709 |
| Fil+A+ | 12 | Loa loa | 3.5 | 3.3 | 4,969.0 | 1,334 |
| Fil+A− | 1 | Loa loa | 0.0 | - | 43.3 | 1,240 |
| Fil+A− | 2 | Loa loa | 0.0 | - | 115.0 | 560 |
| Fil+A− | 3 | Loa loa | 0.0 | - | 187.0 | 141 |
| Fil+A− | 4 | Loa loa | 0.0 | - | 33.9 | 4,104 |
| Fil+A− | 5 | Loa loa | 0.0 | - | 2,794.0 | 675 |
| Fil+A− | 6 | Loa loa | 0.0 | - | 106.0 | 1,650 |
| Fil+A− | 7 | O. volvulus | 0.0 | - | 172.0 | 252 |
| Fil+A− | 8 | W. bancrofti | 0.0 | - | 99.2 | 88 |
| Fil+A− | 9 | Loa loa | 0.0 | - | 787.0 | 1,580 |
| Fil+A− | 10 | W. bancrofti | 0.0 | - | 26.0 | 200 |
| Fil+A− | 11 | Loa loa | 0.0 | - | 28.0 | 960 |
| Fil−A+ | 1 | Negative | 21.9 | 3.5 | 457.0 | - |
| Fil−A+ | 2 | Negative | 5.6 | 2.6 | 107.0 | - |
| Fil−A+ | 3 | Negative | 11.9 | 8.7 | 43.8 | - |
| Fil−A+ | 4 | Negative | 11.1 | 0.8 | 35.2 | - |
| Fil−A+ | 5 | Negative | 24.1 | 5.7 | 74.3 | - |
| Fil−A+ | 6 | Negative | 13.7 | 1.2 | 283.0 | - |
| Fil−A+ | 7 | Negative | 7.7 | 6.8 | 10.7 | - |
| Fil−A+ | 8 | Negative | 26.6 | 8.1 | 60.1 | - |
| Fil−A+ | 9 | Negative | 5.6 | 2.6 | 18.4 | - |
| Fil−A+ | 10 | Negative | 2.7 | 2.0 | 63.2 | - |
| Fil−A+ | 11 | Negative | 14.5 | 2.1 | 121.8 | - |
| Fil−A+ | 12 | Negative | 56.0 | 0.4 | 399.3 | - |
| Fil−A+ | 13 | Negative | 39.8 | 9.4 | 191.1 | - |
| Fil−A− | 1 | Negative | 0.0 | - | 5.6 | - |
| Fil−A− | 2 | Negative | 0.0 | - | 8.4 | - |
| Fil−A− | 3 | Negative | 0.0 | - | 2.4 | - |
| Fil−A− | 4 | Negative | 0.0 | - | 9.7 | - |
| Fil−A− | 5 | Negative | 0.0 | - | 8.9 | - |
| Fil−A− | 6 | Negative | 0.0 | - | 24.3 | - |
| Fil−A− | 7 | Negative | 0.0 | - | 2.0 | - |
| Fil−A− | 8 | Negative | 0.0 | - | 143.0 | - |
| Fil−A− | 9 | Negative | 0.0 | - | 7.1 | - |
| Fil−A− | 10 | Negative | 0.0 | - | 81.1 | - |
| Fil−A− | 11 | Negative | 0.0 | - | 2.6 | - |
| Fil−A− | 12 | Negative | 0.0 | - | 3.1 | - |
| Fil−A− | 13 | Negative | 0.0 | - | 7.7 | - |
*
Allergens specific-IgE levels > 0.35 kUA/L were considered allergic/atopic.